IraZackonMD

Oncology • Albany, NY

Hematologic Oncology

Physician

Join to view full profile

Dr. Zackon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Zackon's full profile

Already have an account?

Office
43 New Scotland Ave
# MC-13
Albany, NY 12208
Phone+1 518-262-6696

Fax+1 518-373-3931

Education & Training

McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 1992 - 1994
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 1990 - 1992
McGill University Faculty Medicine HospitalInternal Medicine, 1986 - 1989
McGill University Faculty of MedicineClass of 1986

Certifications & Licensure

NY State Medical License 1997 - 2026
IL State Medical License 1992 - 1996
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma Start of enrollment: 2012 Feb 01
Unknown status
Phase 1, Phase 2
Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation Start of enrollment: 2018 Jan 01
Completed
Not Applicable

Publications & Presentations

PubMed

29 citations
A Phase I/II Study of Evofosfamide, A Hypoxia-activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma
Jacob P. Laubach, Chia Jen Liu, Noopur Raje, Andrew Yee, Philippe Armand
Clinical Cancer Research. 2019-01-15
5 citations
Hemorrhagic Cystitis Secondary to Adenovirus and BK Virus Infection in a Diffuse Large B-Cell Lymphoma Patient with Recent CAR T-Cell Therapy
Abdul Moiz Khan, Zainub Ajmal, Fatima Tuz Zahra, Ananthakrishnan Ramani, Ira Zackon
Case Reports in Hematology. 2020-11-27
1 citations
Phase I trial of intravenous carboplatin added to oral etoposide and oral cyclophosphamide for stage IV non-small cell lung cancer.
Steven M. Grunberg, John W. Valentine, Ira Zackon, Paul Unger
Investigational New Drugs. 1995-12-01

Journal Articles

A Phase 1/2 Study of Evofosfamide, A Hypoxia-Activated Prodrug with or Without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma
Noopur S Raje, Ira Zackon, Clinical Cancer Research